Teacher Retirement System of Texas Purchases New Position in Cellebrite DI Ltd. (NASDAQ:CLBT)

Teacher Retirement System of Texas purchased a new stake in shares of Cellebrite DI Ltd. (NASDAQ:CLBT) in the fourth quarter, Holdings Channel.com reports. The institutional investor purchased 20,070 shares of the company’s stock, valued at approximately $442,000.

Several other institutional investors and hedge funds have also bought and sold shares of CLBT. Juncture Wealth Strategies LLC raised its holdings in shares of Cellebrite DI by 0.8% during the fourth quarter. Juncture Wealth Strategies LLC now owns 60,003 shares of the company’s stock valued at $1,322,000 after acquiring an additional 505 shares in the last quarter. Strategic Advisors LLC increased its position in Cellebrite DI by 3.4% during the 4th quarter. Strategic Advisors LLC now owns 29,082 shares of the company’s stock valued at $641,000 after purchasing an additional 950 shares during the period. Steward Partners Investment Advisory LLC raised its holdings in Cellebrite DI by 12.1% in the 4th quarter. Steward Partners Investment Advisory LLC now owns 13,590 shares of the company’s stock worth $299,000 after purchasing an additional 1,463 shares in the last quarter. Quarry LP purchased a new stake in shares of Cellebrite DI in the 3rd quarter worth about $27,000. Finally, Tower View Wealth Management LLC boosted its stake in shares of Cellebrite DI by 1.3% during the 4th quarter. Tower View Wealth Management LLC now owns 132,307 shares of the company’s stock valued at $2,915,000 after purchasing an additional 1,660 shares in the last quarter. Hedge funds and other institutional investors own 45.88% of the company’s stock.

Cellebrite DI Stock Down 0.2 %

Shares of CLBT opened at $19.43 on Tuesday. The stock has a market cap of $4.65 billion, a P/E ratio of -13.98, a P/E/G ratio of 4.27 and a beta of 1.52. The business’s 50 day moving average price is $20.78 and its 200-day moving average price is $19.93. Cellebrite DI Ltd. has a 52 week low of $10.25 and a 52 week high of $26.30.

Cellebrite DI (NASDAQ:CLBT) last released its earnings results on Thursday, February 13th. The company reported $0.07 EPS for the quarter, missing analysts’ consensus estimates of $0.10 by ($0.03). Cellebrite DI had a positive return on equity of 58.70% and a negative net margin of 70.54%. On average, equities analysts anticipate that Cellebrite DI Ltd. will post 0.3 EPS for the current year.

Analyst Upgrades and Downgrades

Several brokerages have commented on CLBT. Lake Street Capital raised their price objective on shares of Cellebrite DI from $17.00 to $26.00 and gave the stock a “buy” rating in a report on Friday, February 14th. Needham & Company LLC reissued a “buy” rating and issued a $28.00 target price on shares of Cellebrite DI in a research report on Thursday, March 27th. Finally, JPMorgan Chase & Co. lifted their price target on Cellebrite DI from $24.00 to $28.00 and gave the company an “overweight” rating in a research report on Tuesday, February 11th. Seven analysts have rated the stock with a buy rating, According to MarketBeat, the stock presently has a consensus rating of “Buy” and an average target price of $23.43.

Cellebrite DI Company Profile

Cellebrite DI Ltd. develops solutions for legally sanctioned investigations in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. The company's DI suite of solutions allows users to collect, review, analyze, and manage digital data across the investigative lifecycle with respect to legally sanctioned investigations used in various cases, including child exploitation, homicide, anti-terror, border control, sexual crimes, human trafficking, corporate security, cryptocurrency, and intellectual property theft.